First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Successfully Completed in Brazil

Food and Healthcare Press Releases Monday December 25, 2017 09:05
SAO PAULO--25 Dec--PRNewswire/InfoQuest

On December 19, 2017, local time, 4 clinical implantations of transcatheter pulmonary valve VenusP-Valve were successfully completed in Brazil by Professor Carlos Pedra from Dante Pazzanese Institute of Cardiovascular Technology in Sao Paulo, Brazil.

After Chile and Argentina, Brazil becomes the third Latin American country to apply the valve of Venus Medtech (Hangzhou) Inc. It also marks the first application of China-made heart valves in Brazilian history.

At present, in every 10,000 newborns in the world, there are 16 newborns that will need surgery because of congenital heart defects. This kind of surgery can cause mass pulmonary regurgitation. Currently the interventional pulmonary valve products in the global market can only treat patients with special anatomical structure and light illness. As a result, a large number of patients with complex anatomical structure and poor right heart function are in urgent need of an interventional pulmonary valve product that could treat different anatomical structure and be operated with ease, safety and stability.

Venus Medtech (Hangzhou) Inc. has developed and manufactured transcatheter pulmonary valve VenusP-Valve, the world's first self-expanding interventional pulmonary valve. With unique double trumpet-shaped designs and laser cutting technology for valve stent, VenusP-Valve is endowed with a strong radial support force, stable anchoring, and easy release. No movement or displacement will occur during the release process. It can meet the needs of pulmonary arteries with different anatomical structures and features the only interventional pulmonary valve in the world that can treat patients with a large size of right ventricular outflow tract.

After the first successful human implantation by Academician Ge Junbo in Zhongshan Hospital, Shanghai on May 25, 2013, VenusP-Valve has entered more than 20 countries in Asia, Europe and America. At present, the clinical trial of the Chinese Food and Drug Administration (CFDA) has been finished; the process of European CE clinical trial has entered more than half of the period; communication with the United States' Food and Drug Administration (FDA) has been completed, with the start of the clinical trial before launching in USA. It is hoped that VenusP-Valve, with superior clinical results, can be approved as early as possible to provide optimal treatment for more patients.

Photo - https://photos.prnasia.com/prnh/20171222/2021378-1
Caption - First Successful Clinical Implantation of Transcatheter Pulmonary Artery Valve Venus P-Valve in Brazil

Latest Press Release

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens# FibroScan(R), Imposes Damages Orders Halt to Manufacturing and Sales

Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today announces that the Beijing Intellectual Property Court has confirmed judgment against Wuxi Hisky Medical,...

5 Ways to Set Healthy Grocery Shopping Habits in 2019

By Susan Bowerman, M.S., RD, CSSD, CSOWM, FAN, Senior Director, Worldwide Nutrition Education and Training Make your daily staples as healthy as you can. Small changes in the foods you eat every day can add up to big rewards. The holidays are over, and...

Related Topics